IN8bio, Inc.
INAB
$1.55
-$0.11-6.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 0.97% | 2.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.11% | -9.06% | |||
| Operating Income | 8.11% | 9.06% | |||
| Income Before Tax | 8.22% | 9.90% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 8.22% | 9.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.22% | 9.90% | |||
| EBIT | 8.11% | 9.06% | |||
| EBITDA | 9.76% | 10.02% | |||
| EPS Basic | 37.99% | 16.78% | |||
| Normalized Basic EPS | 37.99% | 16.77% | |||
| EPS Diluted | 37.99% | 16.78% | |||
| Normalized Diluted EPS | 37.99% | 16.77% | |||
| Average Basic Shares Outstanding | 48.03% | 8.26% | |||
| Average Diluted Shares Outstanding | 48.03% | 8.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||